{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34211570", "DateRevised": {"Year": "2023", "Month": "09", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "08"}], "Language": ["eng"], "ELocationID": ["5578574", "10.1155/2021/5578574"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2021", "PubDate": {"Year": "2021"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease.", "Pagination": {"StartPage": "5578574", "MedlinePgn": "5578574"}, "Abstract": {"AbstractText": ["Since primitive times, herbs have been extensively used in conventional remedies for boosting cognitive impairment and age-associated memory loss. It is mentioned that medicinal plants have a variety of dynamic components, and they have become a prominent choice for synthetic medications for the care of cognitive and associated disorders. Herbal remedies have played a major role in the progression of medicine, and many advanced drugs have already been developed. Many studies have endorsed practicing herbal remedies with phytoconstituents, for healing Alzheimer's disease (AD). All the information in this article was collated from selected research papers from online scientific databases, such as PubMed, Web of Science, and Scopus. The aim of this article is to convey the potential of herbal remedies for the prospect management of Alzheimer's and related diseases. Herbal remedies may be useful in the discovery and advancement of drugs, thus extending new leads for neurodegenerative diseases such as AD. Nanocarriers play a significant role in delivering herbal medicaments to a specific target. Therefore, many drugs have been described for the management of age-linked complaints such as dementia, AD, and the like. Several phytochemicals are capable of managing AD, but their therapeutic claims are restricted due to their lower solubility and metabolism. These limitations of natural therapeutics can be overcome by using a targeted nanocarrier system. This article will provide the primitive remedies as well as the development of herbal remedies for AD management."], "CopyrightInformation": "Copyright \u00a9 2021 Anurag Kumar Singh et al."}, "AuthorList": [{"Identifier": ["0000-0003-2125-810X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India."}], "LastName": "Singh", "ForeName": "Anurag Kumar", "Initials": "AK"}, {"Identifier": ["0000-0001-8418-9549"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre of Biotechnology, University of Allahabad, Prayagraj 211002, India."}], "LastName": "Rai", "ForeName": "Sachchida Nand", "Initials": "SN"}, {"Identifier": ["0000-0001-6591-4135"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India."}], "LastName": "Maurya", "ForeName": "Anand", "Initials": "A"}, {"Identifier": ["0000-0002-8969-0014"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India."}], "LastName": "Mishra", "ForeName": "Gaurav", "Initials": "G"}, {"Identifier": ["0000-0002-1286-1874"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida 201303, Uttar Pradesh, India."}], "LastName": "Awasthi", "ForeName": "Rajendra", "Initials": "R"}, {"Identifier": ["0000-0002-8232-4476"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Assam 786004, Dibrugarh, India."}], "LastName": "Shakya", "ForeName": "Anshul", "Initials": "A"}, {"Identifier": ["0000-0001-5567-6663"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur 57000, Malaysia."}], "LastName": "Chellappan", "ForeName": "Dinesh Kumar", "Initials": "DK"}, {"Identifier": ["0000-0002-7507-1159"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Ultimo, New South Wales, Australia."}], "LastName": "Dua", "ForeName": "Kamal", "Initials": "K"}, {"Identifier": ["0000-0002-3376-2058"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Biotechnology, University of Agronomic Science and Veterinary Medicine, 59 Marasti Blvd, 1 District, 011464, Bucharest, Romania."}], "LastName": "Vamanu", "ForeName": "Emanuel", "Initials": "E"}, {"Identifier": ["0000-0002-7964-0021"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, DIT University, Mussoorie-Diversion Road, Makkawala, Dehradun 248 009, Uttarakhand, India."}], "LastName": "Chaudhary", "ForeName": "Sushil Kumar", "Initials": "SK"}, {"Identifier": ["0000-0002-6236-856X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre of Biotechnology, University of Allahabad, Prayagraj 211002, India."}], "LastName": "Singh", "ForeName": "M P", "Initials": "MP"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Singh A. K., Mishra G., Maurya A., et al. Role of TREM2 in Alzheimer\u2019s disease and its consequences on \u03b2-amyloid, tau and neurofibrillary tangles. Current Alzheimer Research. 2019;16(13):1216\u20131229. doi: 10.2174/1567205016666190903102822.", "ArticleIdList": ["10.2174/1567205016666190903102822", "31481003"]}, {"Citation": "Herrup K. The case for rejecting the amyloid cascade hypothesis. Nature Neuroscience. 2015;18(6):794\u2013799. doi: 10.1038/nn.4017.", "ArticleIdList": ["10.1038/nn.4017", "26007212"]}, {"Citation": "Singh A. K., Singh S. K., Nandi M. K., et al. Berberine: a plant-derived alkaloid with therapeutic potential to combat Alzheimer\u2019s disease. Central Nervous System Agents in Medicinal Chemistry. 2019;19(3):154\u2013170. doi: 10.2174/1871524919666190820160053.", "ArticleIdList": ["10.2174/1871524919666190820160053", "31429696"]}, {"Citation": "Ardura-Fabregat A., Boddeke E. W. G. M., Boza-Serrano A., et al. Targeting neuroinflammation to treat Alzheimer\u2019s disease. CNS Drugs. 2017;31(12):1057\u20131082. doi: 10.1007/s40263-017-0483-3.", "ArticleIdList": ["10.1007/s40263-017-0483-3", "PMC5747579", "29260466"]}, {"Citation": "Zhong K. L., Chen F., Hong H., et al. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer\u2019s disease. Metabolic Brain Disease. 2018;33(4):1009\u20131018. doi: 10.1007/s11011-018-0227-1.", "ArticleIdList": ["10.1007/s11011-018-0227-1", "29626315"]}, {"Citation": "Friedman L. G., Qureshi Y. H., Yu W. H. Promoting autophagic clearance: viable therapeutic targets in Alzheimer\u2019s disease. Neurotherapeutics. 2015;12(1):94\u2013108. doi: 10.1007/s13311-014-0320-z.", "ArticleIdList": ["10.1007/s13311-014-0320-z", "PMC4322072", "25421002"]}, {"Citation": "Sanabria-Castro A., Alvarado-Echeverr\u00eda I., Monge-Bonilla C. Molecular pathogenesis of Alzheimer\u2019s disease: an update. Annals of Neurosciences. 2017;24(1):46\u201354. doi: 10.1159/000464422.", "ArticleIdList": ["10.1159/000464422", "PMC5448443", "28588356"]}, {"Citation": "Jevtic S., Sengar A. S., Salter M. W., McLaurin J. The role of the immune system in Alzheimer disease: etiology and treatment. Ageing Research Reviews. 2017;40:84\u201394. doi: 10.1016/j.arr.2017.08.005.", "ArticleIdList": ["10.1016/j.arr.2017.08.005", "28941639"]}, {"Citation": "Ghosh A., Chen F., Wu F., et al. CysLT1R downregulation reverses intracerebroventricular streptozotocin-induced memory impairment via modulation of neuroinflammation in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2017;73:19\u201330. doi: 10.1016/j.pnpbp.2016.10.001.", "ArticleIdList": ["10.1016/j.pnpbp.2016.10.001", "27720931"]}, {"Citation": "Laurent C., Bu\u00e9e L., Blum D. Tau and neuroinflammation: what impact for Alzheimer\u2019s disease and tauopathies? Biomedical Journal. 2018;41(1):21\u201333. doi: 10.1016/j.bj.2018.01.003.", "ArticleIdList": ["10.1016/j.bj.2018.01.003", "PMC6138617", "29673549"]}, {"Citation": "Shimmyo Y., Kihara T., Akaike A., Niidome T., Sugimoto H. Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochimica et Biophysica Acta (BBA)-General Subjects. 2008;1780(5):819\u2013825. doi: 10.1016/j.bbagen.2008.01.017.", "ArticleIdList": ["10.1016/j.bbagen.2008.01.017", "18295609"]}, {"Citation": "Shimmyo Y., Kihara T., Akaike A., Niidome T., Sugimoto H. Multifunction of myricetin on A\u03b2: neuroprotection via a conformational change of A\u03b2 and reduction of A\u03b2 via the interference of secretases. Journal of Neuroscience Research. 2008;86(2):368\u2013377. doi: 10.1002/jnr.21476.", "ArticleIdList": ["10.1002/jnr.21476", "17722071"]}, {"Citation": "Mori T., Rezai-Zadeh K., Koyama N., et al. Tannic acid is a natural \u03b2-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. Journal of Biological Chemistry. 2012;287(9):6912\u20136927. doi: 10.1074/jbc.m111.294025.", "ArticleIdList": ["10.1074/jbc.m111.294025", "PMC3307267", "22219198"]}, {"Citation": "Thapa A., Woo E.-R., Chi E. Y., et al. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-\u03b2 toxicity and Fibrillogenesis via accumulation of nontoxic oligomer-like structures. Biochemistry. 2011;50(13):2445\u20132455. doi: 10.1021/bi101731d.", "ArticleIdList": ["10.1021/bi101731d", "21322641"]}, {"Citation": "Klein W. L. A\u03b2 toxicity in Alzheimer\u2019s disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochemistry International. 2002;41(5):345\u2013352. doi: 10.1016/s0197-0186(02)00050-5.", "ArticleIdList": ["10.1016/s0197-0186(02)00050-5", "12176077"]}, {"Citation": "Liu Y., Walter S., Stagi M., et al. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer\u2019s amyloid peptide. Brain. 2005;128(8):1778\u20131789. doi: 10.1093/brain/awh531.", "ArticleIdList": ["10.1093/brain/awh531", "15857927"]}, {"Citation": "Walsh D. M., Selkoe D. J. A\u03b2 oligomers-a decade of discovery. Journal of Neurochemistry. 2007;101(5):1172\u20131184. doi: 10.1111/j.1471-4159.2006.04426.x.", "ArticleIdList": ["10.1111/j.1471-4159.2006.04426.x", "17286590"]}, {"Citation": "Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer\u2019s disease. Journal of Neurochemistry. 2003;87(1):172\u2013181. doi: 10.1046/j.1471-4159.2003.01976.x.", "ArticleIdList": ["10.1046/j.1471-4159.2003.01976.x", "12969264"]}, {"Citation": "Lou H., Fan P., Perez R. G., Lou H. Neuroprotective effects of linarin through activation of the PI3K/Akt pathway in amyloid-\u03b2-induced neuronal cell death. Bioorganic & Medicinal Chemistry. 2011;19(13):4021\u20134027. doi: 10.1016/j.bmc.2011.05.021.", "ArticleIdList": ["10.1016/j.bmc.2011.05.021", "21652214"]}, {"Citation": "Gil B., Sanz M. J., Terencio M. C., Gunasegaran R., Pay\u00e1 M., Alcaraz M. J. Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity. Biochemical Pharmacology. 1997;53(5):733\u2013740. doi: 10.1016/s0006-2952(96)00773-3.", "ArticleIdList": ["10.1016/s0006-2952(96)00773-3", "9113093"]}, {"Citation": "\u0160vagera Z., Skottov\u00e1 N., V\u00e1na P., et al. Plasma lipoproteins in transport of silibinin, an antioxidant flavonolignan from Silybum marianum. Phytotherapy Research: PTR. 2003;17(5):524\u2013530. doi: 10.1002/ptr.1187.", "ArticleIdList": ["10.1002/ptr.1187", "12748991"]}, {"Citation": "Wang M., Li Y.-J., Ding Y., et al. Silibinin prevents autophagic cell death upon oxidative stress in cortical neurons and cerebral ischemia-reperfusion injury. Molecular Neurobiology. 2016;53(2):932\u2013943. doi: 10.1007/s12035-014-9062-5.", "ArticleIdList": ["10.1007/s12035-014-9062-5", "25561437"]}, {"Citation": "Cai Z., Liu N., Wang C., et al. Role of RAGE in Alzheimer\u2019s disease. Cellular and Molecular Neurobiology. 2016;36(4):483\u2013495. doi: 10.1007/s10571-015-0233-3.", "ArticleIdList": ["10.1007/s10571-015-0233-3", "26175217"]}, {"Citation": "Derk J., MacLean M., Juranek J., Schmidt A. M. The receptor for advanced glycation endproducts (RAGE) and mediation of inflammatory neurodegeneration. Journal of Alzheimer\u2019s Disease & Parkinsonism. 2018;8(1)", "ArticleIdList": ["PMC6293973", "30560011"]}, {"Citation": "Kametani F., Hasegawa M. Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease. Frontiers in Neuroscience. 2018;12:p. 25. doi: 10.3389/fnins.2018.00025.", "ArticleIdList": ["10.3389/fnins.2018.00025", "PMC5797629", "29440986"]}, {"Citation": "Kikuchi K., Kidana K., Tatebe T., Tomita T. Dysregulated metabolism of the amyloid-\u03b2 protein and therapeutic approaches in Alzheimer disease. Journal of Cellular Biochemistry. 2017;118(12):4183\u20134190. doi: 10.1002/jcb.26129.", "ArticleIdList": ["10.1002/jcb.26129", "28488760"]}, {"Citation": "Walsh D. M., Teplow D. B. Alzheimer\u2019s disease and the amyloid \u03b2-protein. Progress in Molecular Biology and Translational Science. 2012;107:101\u2013124. doi: 10.1016/b978-0-12-385883-2.00012-6.", "ArticleIdList": ["10.1016/b978-0-12-385883-2.00012-6", "22482449"]}, {"Citation": "Metaxas A., Kempf S. J. Neurofibrillary tangles in Alzheimer\u2019s disease: elucidation of the molecular mechanism by immunohistochemistry and tau protein phospho-proteomics. Neural Regeneration Research. 2016;11(10):1579\u20131581. doi: 10.4103/1673-5374.193234.", "ArticleIdList": ["10.4103/1673-5374.193234", "PMC5116834", "27904486"]}, {"Citation": "Chen F., Ghosh A., Lin J., et al. 5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer\u2019s disease. Brain, Behavior, and Immunity. 2020;88 doi: 10.1016/j.bbi.2020.03.022.", "ArticleIdList": ["10.1016/j.bbi.2020.03.022", "32222525"]}, {"Citation": "Morales I., Jim\u00e9nez J. M., Mancilla M., Maccioni R. B. Tau oligomers and fibrils induce activation of microglial cells. Journal of Alzheimer\u2019s Disease. 2013;37(4):849\u2013856. doi: 10.3233/jad-131843.", "ArticleIdList": ["10.3233/jad-131843", "23948931"]}, {"Citation": "Cummings J., Lee G., Ritter A., Sabbagh M., Zhong K. Alzheimer\u2019s disease drug development pipeline: 2019. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions. 2019;5(1):272\u2013293. doi: 10.1016/j.trci.2019.05.008.", "ArticleIdList": ["10.1016/j.trci.2019.05.008", "PMC6617248", "31334330"]}, {"Citation": "Korolev I. O. Alzheimer\u2019s disease: a clinical and basic science review. Medical Student Research Journal. 2014;4(1):24\u201333."}, {"Citation": "Holtzman D. M., Morris J. C., Goate A. M. Alzheimer\u2019s disease: the challenge of the second century. Science Translational Medicine. 2011;3(77):p. 77sr1. doi: 10.1126/scitranslmed.3002369.", "ArticleIdList": ["10.1126/scitranslmed.3002369", "PMC3130546", "21471435"]}, {"Citation": "DiSabato D. J., Quan N., Godbout J. P. Neuroinflammation: the devil is in the details. Journal of Neurochemistry. 2016;139:136\u2013153. doi: 10.1111/jnc.13607.", "ArticleIdList": ["10.1111/jnc.13607", "PMC5025335", "26990767"]}, {"Citation": "Minghetti L. Role of COX-2 in inflammatory and degenerative brain diseases. Subcellular Biochemistry. 2007;42:127\u2013141. doi: 10.1007/1-4020-5688-5_5.", "ArticleIdList": ["10.1007/1-4020-5688-5_5", "17612048"]}, {"Citation": "Calsolaro V., Edison P. Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimer\u2019s & Dementia. 2016;12(6):719\u2013732. doi: 10.1016/j.jalz.2016.02.010.", "ArticleIdList": ["10.1016/j.jalz.2016.02.010", "27179961"]}, {"Citation": "Bettcher B. M., Johnson S. C., Fitch R., et al. Cerebrospinal fluid and plasma levels of inflammation differentially relate to CNS markers of Alzheimer\u2019s disease pathology and neuronal damage. Journal of Alzheimer\u2019s Disease. 2018;62(1):385\u2013397. doi: 10.3233/jad-170602.", "ArticleIdList": ["10.3233/jad-170602", "PMC6007886", "29439331"]}, {"Citation": "Akiyama H., Barger S., Barnum S., et al. Inflammation and Alzheimer\u2019s disease. Neurobiology of Aging. 2000;21(3):383\u2013421. doi: 10.1016/s0197-4580(00)00124-x.", "ArticleIdList": ["10.1016/s0197-4580(00)00124-x", "PMC3887148", "10858586"]}, {"Citation": "Norden D. M., Godbout J. P. Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathology and Applied Neurobiology. 2013;39(1):19\u201334. doi: 10.1111/j.1365-2990.2012.01306.x.", "ArticleIdList": ["10.1111/j.1365-2990.2012.01306.x", "PMC3553257", "23039106"]}, {"Citation": "Bonifati D., Kishore U. Role of complement in neurodegeneration and neuroinflammation. Molecular Immunology. 2007;44(5):999\u20131010. doi: 10.1016/j.molimm.2006.03.007.", "ArticleIdList": ["10.1016/j.molimm.2006.03.007", "16698083"]}, {"Citation": "Morales I., Guzm\u00e1n-Mart\u00ednez L., Cerda-Troncoso C., Far\u00edas G. A., Maccioni R. B. Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches. Which New Directions for Alzheimer\u2019s Disease. 2015;8 doi: 10.3389/fncel.2014.00112.", "ArticleIdList": ["10.3389/fncel.2014.00112", "PMC4001039", "24795567"]}, {"Citation": "Boche D., Perry V. H., Nicoll J. A. R. Review: activation patterns of microglia and their identification in the human brain. Neuropathology and Applied Neurobiology. 2013;39(1):3\u201318. doi: 10.1111/nan.12011.", "ArticleIdList": ["10.1111/nan.12011", "23252647"]}, {"Citation": "Van Beek T. A. Chemical analysis of Ginkgo biloba leaves and extracts. Journal of Chromatography A. 2002;967(1):21\u201355. doi: 10.1016/s0021-9673(02)00172-3.", "ArticleIdList": ["10.1016/s0021-9673(02)00172-3", "12219929"]}, {"Citation": "Le Bars P. L., Katz M. M., Berman N., Itil T. M., Freedman A. M., Schatzberg A. F. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA: The Journal of the American Medical Association. 1997;278(16):1327\u20131332. doi: 10.1001/jama.1997.03550160047037.", "ArticleIdList": ["10.1001/jama.1997.03550160047037", "9343463"]}, {"Citation": "Herrschaft H., Nacu A., Likhachev S., Sholomov I., Hoerr R., Schlaefke S. Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. Journal of Psychiatric Research. 2012;46(6):716\u2013723. doi: 10.1016/j.jpsychires.2012.03.003.", "ArticleIdList": ["10.1016/j.jpsychires.2012.03.003", "22459264"]}, {"Citation": "Sage, \u201cOBe Wise Nutriceutica. Applied Health,\u201d 2008."}, {"Citation": "Spiridonov N. A., Arkhipov V. V., Foigel A. G., Shipulina L. D., Fomkina M. G. Protonophoric and uncoupling activity of royleanones from Salvia officinalis and euvimals from Eucalyptus viminalis. Phytotherapy Research. 2003;17(10):1228\u20131230. doi: 10.1002/ptr.1403.", "ArticleIdList": ["10.1002/ptr.1403", "14669263"]}, {"Citation": "Akhondzadeh S., Noroozian M., Mohammadi M., Ohadinia S., Jamshidi A. H., Khani M. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer\u2019s disease: a double blind, randomized and placebo-controlled trial. Journal of Clinical Pharmacy and Therapeutics. 2003;28(1):53\u201359. doi: 10.1046/j.1365-2710.2003.00463.x.", "ArticleIdList": ["10.1046/j.1365-2710.2003.00463.x", "12605619"]}, {"Citation": "Moss M., Cook J., Wesnes K., Duckett P. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. International Journal of Neuroscience. 2003;113(1):15\u201338. doi: 10.1080/00207450390161903.", "ArticleIdList": ["10.1080/00207450390161903", "12690999"]}, {"Citation": "Katerinopoulos H. E., Pagona G., Afratis A., Stratigakis N., Roditakis N. Composition and insect attracting activity of the essential oil of Rosmarinus officinalis. Journal of Chemical Ecology. 2005;31(1):111\u2013122. doi: 10.1007/s10886-005-0978-0.", "ArticleIdList": ["10.1007/s10886-005-0978-0", "15839484"]}, {"Citation": " Newstarget uncensored and independent media news, 2021,  http://www.naturalnews.com."}, {"Citation": "Henrotin Y., Clutterbuck A. L., Allaway D., et al. Biological actions of curcumin on articular chondrocytes. Osteoarthritis and Cartilage. 2010;18(2):141\u2013149. doi: 10.1016/j.joca.2009.10.002.", "ArticleIdList": ["10.1016/j.joca.2009.10.002", "19836480"]}, {"Citation": "Funk J. L., Frye J. B., Oyarzo J. N., et al. Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis. Arthritis & Rheumatism. 2006;54(11):3452\u20133464. doi: 10.1002/art.22180.", "ArticleIdList": ["10.1002/art.22180", "17075840"]}, {"Citation": "Mishra S., Palanivelu K. The effect of curcumin (turmeric) on Alzheimer\u2019s disease: An overview. Annals of Indian Academy of Neurology. 2008;11(1):p. 13. doi: 10.4103/0972-2327.40220.", "ArticleIdList": ["10.4103/0972-2327.40220", "PMC2781139", "19966973"]}, {"Citation": "Tawab M. A., Bahr U., Karas M., Wurglics M., Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metabolism and Disposition. 2003;31(8):1065\u20131071. doi: 10.1124/dmd.31.8.1065.", "ArticleIdList": ["10.1124/dmd.31.8.1065", "12867496"]}, {"Citation": "Imbimbo B. Therapeutic potential of \u03b3-secretase inhibitors and modulators. Current Topics in Medicinal Chemistry. 2008;8(1):54\u201361. doi: 10.2174/156802608783334015.", "ArticleIdList": ["10.2174/156802608783334015", "18220933"]}, {"Citation": "Cho I.-H. Effects of Panax ginseng in neurodegenerative diseases. Journal of Ginseng Research. 2012;36(4):342\u2013353. doi: 10.5142/jgr.2012.36.4.342.", "ArticleIdList": ["10.5142/jgr.2012.36.4.342", "PMC3659610", "23717136"]}, {"Citation": "Rhode J., Fogoros S., Zick S., et al. Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complementary and Alternative Medicine. 2007;7(1):44\u201349. doi: 10.1186/1472-6882-7-44.", "ArticleIdList": ["10.1186/1472-6882-7-44", "PMC2241638", "18096028"]}, {"Citation": "Abdel-Aziz H., Windeck T., Ploch M., Verspohl E. J. Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated Guinea-pig ileum. European Journal of Pharmacology. 2006;530(1-2):136\u2013143. doi: 10.1016/j.ejphar.2005.10.049.", "ArticleIdList": ["10.1016/j.ejphar.2005.10.049", "16364290"]}, {"Citation": "Nievergelt A., Huonker P., Schoop R., Altmann K.-H., Gertsch J. Identification of serotonin 5-HT1A receptor partial agonists in ginger. Bioorganic & Medicinal Chemistry. 2010;18(9):3345\u20133351. doi: 10.1016/j.bmc.2010.02.062.", "ArticleIdList": ["10.1016/j.bmc.2010.02.062", "20363635"]}, {"Citation": "Kavalali G. M., editor. Urtica: The Genus Urtica. Boca Raton, FL, USA: CRC Press; 2003."}, {"Citation": " Naturalpedia, 2021,  http://www.naturalpedia.com."}, {"Citation": "Safarinejad M. R. Urtica dioicafor treatment of benign prostatic hyperplasia. Journal of Herbal Pharmacotherapy. 2005;5(4):1\u201311. doi: 10.1080/j157v05n04_01.", "ArticleIdList": ["10.1080/j157v05n04_01", "16635963"]}, {"Citation": "Gonzales G. F., Miranda S., Nieto J., et al. Red maca (Lepidium meyenii) reduced prostate size in rats. Reproductive Biology and Endocrinology: RB&E. 2005;3(1):5\u201316. doi: 10.1186/1477-7827-3-5.", "ArticleIdList": ["10.1186/1477-7827-3-5", "PMC548136", "15661081"]}, {"Citation": "Gonzales G. F., Cordova A., Vega K., et al. Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia. 2002;34(6):367\u2013372. doi: 10.1046/j.1439-0272.2002.00519.x.", "ArticleIdList": ["10.1046/j.1439-0272.2002.00519.x", "12472620"]}, {"Citation": "Yuan S. Q., Zhao Y. M. A novel phlegmariurine type alkaloid from Huperziaserrata (Thunb.) Trev. Yao Xue Xue Bao\u2009=\u2009Acta Pharmaceutica Sinica. 2003;38(8):596\u2013598.", "ArticleIdList": ["14628450"]}, {"Citation": "Rafii M. S., Walsh S., Little J. T., et al. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 2011;76(16):1389\u20131394. doi: 10.1212/wnl.0b013e318216eb7b.", "ArticleIdList": ["10.1212/wnl.0b013e318216eb7b", "PMC3269774", "21502597"]}, {"Citation": "Wang B.-s., Wang H., Wei Z.-h., Song Y.-y., Zhang L., Chen H.-z. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer\u2019s disease: an updated meta-analysis. Journal of Neural Transmission. 2009;116(4):457\u2013465. doi: 10.1007/s00702-009-0189-x.", "ArticleIdList": ["10.1007/s00702-009-0189-x", "19221692"]}, {"Citation": "Ali Z., Khan I. A. Chemical constituents of Terminalia chebula. Planta Medica. 2009;75(04):p. 41. doi: 10.1055/s-2009-1216479.", "ArticleIdList": ["10.1055/s-2009-1216479", "0"]}, {"Citation": "Sancheti S., Sancheti S., Um B.-H., Seo S.-Y. 1,2,3,4,6-penta-O-galloyl-\u03b2-d-glucose: a cholinesterase inhibitor from Terminalia chebula. South African Journal of Botany. 2010;76(2):285\u2013288. doi: 10.1016/j.sajb.2009.11.006.", "ArticleIdList": ["10.1016/j.sajb.2009.11.006"]}, {"Citation": "Chang C. L., Lin C. S. Phytochemical composition, antioxidant activity, and neuroprotective effect of Terminalia chebula retzius extracts. Evidence-Based Complementary and Alternative Medicine. 2012;2012 doi: 10.1155/2012/125247.125247", "ArticleIdList": ["10.1155/2012/125247", "PMC3132459", "21754945"]}, {"Citation": "Matsuda H., Murakami T., Kishi A., Yoshikawa M. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera Dunal. and inhibitory activity for tachyphylaxis to clonidine in isolated Guinea-pig ileum. Bioorganic & Medicinal Chemistry. 2001;9(6):1499\u20131507. doi: 10.1016/s0968-0896(01)00024-4.", "ArticleIdList": ["10.1016/s0968-0896(01)00024-4", "11408168"]}, {"Citation": "Jayaprakasam B., Padmanabhan K., Nair M. G. Withanamides in Withania somnifera fruit protect PC-12 cells from \u03b2-amyloid responsible for Alzheimer\u2019s disease. Phytotherapy Research. 2010;24(6):859\u2013863. doi: 10.1002/ptr.3033.", "ArticleIdList": ["10.1002/ptr.3033", "19957250"]}, {"Citation": "Mishra L. C., Singh B. B., Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Alternative Medicine Review: A Journal of Clinical Therapeutic. 2000;5(4):334\u2013346.", "ArticleIdList": ["10956379"]}, {"Citation": "Wollen K. A. Alzheimer\u2019s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Alternative Medicine Review: A Journal of Clinical Therapeutic. 2010;15(3):223\u2013244.", "ArticleIdList": ["21155625"]}, {"Citation": "Monograph. Withaniasomnifera. Alternative Medicine Review. 2004;9:211\u2013214. doi: 10.1515/9783110918083-012.", "ArticleIdList": ["10.1515/9783110918083-012", "15253680"]}, {"Citation": "Dhuley J. N. Effect of ashwagandha on lipid peroxidation in stress-induced animals. Journal of Ethnopharmacology. 1998;60(2):173\u2013178. doi: 10.1016/s0378-8741(97)00151-7.", "ArticleIdList": ["10.1016/s0378-8741(97)00151-7", "9582008"]}, {"Citation": "Parihar M. S., Hemnani T. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity. Journal of Biosciences. 2003;28(1):121\u2013128. doi: 10.1007/bf02970142.", "ArticleIdList": ["10.1007/bf02970142", "12682435"]}, {"Citation": "Kuboyama T., Tohda C., Zhao J., Nakamura N., Hattori M., Komatsu K. Axon-or dendrite-predominant outgrowth induced by constituents from Ashwagandha. Neuro Report. 2002;13(14):1715\u20131720. doi: 10.1097/00001756-200210070-00005.", "ArticleIdList": ["10.1097/00001756-200210070-00005", "12395110"]}, {"Citation": "Schliebs R., Liebmann A., Bhattacharya S., Kumar A., Ghosal S., Bigl V. Systemic administration of defined extracts from Withania somnifera (Indian ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochemistry International. 1997;30(2):181\u2013190. doi: 10.1016/s0197-0186(96)00025-3.", "ArticleIdList": ["10.1016/s0197-0186(96)00025-3", "9017665"]}, {"Citation": "Kuboyama T., Tohda C., Komatsu K. Neuritic regeneration and synaptic reconstruction induced by withanolide A. British Journal of Pharmacology. 2005;144(7):961\u2013971. doi: 10.1038/sj.bjp.0706122.", "ArticleIdList": ["10.1038/sj.bjp.0706122", "PMC1576076", "15711595"]}, {"Citation": "Sehgal A., Kumar M., Jain M., Dhawan D. Piperine as an adjuvant increases the efficacy of curcumin in mitigating benzo a pyrene toxicity. Human & Experimental Toxicology. 2012;31(5):473\u2013482. doi: 10.1177/0960327111421943.", "ArticleIdList": ["10.1177/0960327111421943", "22027502"]}, {"Citation": "Abbas S. S., Singh N. Anti-stress Agents (Herbs) of Indian Origin\u2013Herbal Drugs, A Twenty First Century Perspective. Delhi, India: Institute of Nuclear Medicine and Allied Sciences, Defence Research and Development Organization (DRDO), Government of India; 2006. pp. 578\u2013591."}, {"Citation": "Ven Murthy M. R., Ranjekar P. K., Ramassamy C., Deshpande M. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: 1. Ashwagandha. Central Nervous System Agents in Medicinal Chemistry. 2010;10(3):238\u2013246. doi: 10.2174/1871524911006030238.", "ArticleIdList": ["10.2174/1871524911006030238", "20528765"]}, {"Citation": "Kumar V. Potential medicinal plants for CNS disorders: an overview. Phytotherapy Research. 2006;20(12):1023\u20131035. doi: 10.1002/ptr.1970.", "ArticleIdList": ["10.1002/ptr.1970", "16909441"]}, {"Citation": "Monograph N. S. Bacopamonniera. Alternative Medicine Review. 2004;9:79\u201385.", "ArticleIdList": ["15005647"]}, {"Citation": "Dhanasekaran M., Tharakan B., Holcomb L. A., Hitt A. R., Young K. A., Manyam B. V. Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera. Phytotherapy Research. 2007;21(10):965\u2013969. doi: 10.1002/ptr.2195.", "ArticleIdList": ["10.1002/ptr.2195", "17604373"]}, {"Citation": "Stough C., Downey L. A., Lloyd J., et al. Examining the nootropic effects of a special extract of Bacopa monnieraon human cognitive functioning: 90 day double-blind placebo-controlled randomized trial. Phytotherapy Research. 2008;22(12):1629\u20131634. doi: 10.1002/ptr.2537.", "ArticleIdList": ["10.1002/ptr.2537", "18683852"]}, {"Citation": "Fu L. M., Li J. T. A systematic review of single Chinese herbs for Alzheimer\u2019s disease treatment. Evidence-Based Complementary and Alternative Medicine. 2011;2011 doi: 10.1093/ecam/nep136.640284", "ArticleIdList": ["10.1093/ecam/nep136"]}, {"Citation": "Shinomol G. K., Bharath M. M. Exploring the role of \u201cBrahmi\u201d(Bacopamonnieri and Centellaasiatica) in brain function and therapy. Recent patents on endocrine, Metabolic & Immune Drug Discovery. 2011;5(1):33\u201349.", "ArticleIdList": ["22074576"]}, {"Citation": "Uabundit N., Wattanathorn J., Mucimapura S., Ingkaninan K. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer\u2019s disease model. Journal of Ethnopharmacology. 2010;127(1):26\u201331. doi: 10.1016/j.jep.2009.09.056.", "ArticleIdList": ["10.1016/j.jep.2009.09.056", "19808086"]}, {"Citation": "Bhattacharya S. K., Bhattacharya A., Kumar A., Ghosal S. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytotherapy Research. 2000;14(3):174\u2013179. doi: 10.1002/(sici)1099-1573(200005)14:3<174::aid-ptr624>3.0.co;2-o.", "ArticleIdList": ["10.1002/(sici)1099-1573(200005)14:3<174::aid-ptr624>3.0.co;2-o", "10815010"]}, {"Citation": "Breitner J., Welsh K. A., Helms M. J., et al. Delayed onset of Alzheimer\u2019s disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiology of Aging. 1995;16(4):523\u2013530. doi: 10.1016/0197-4580(95)00049-k.", "ArticleIdList": ["10.1016/0197-4580(95)00049-k", "8544901"]}, {"Citation": "Aggarwal B. B., Surh Y. J., Shishodia S., editors. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Berlin, Germany: Springer Science & Business Media; 2007."}, {"Citation": "Shishodia S., Sethi G., Aggarwal B. B. Curcumin: getting back to the roots. Annals of the New York Academy of Sciences. 2005;1056(1):206\u2013217. doi: 10.1196/annals.1352.010.", "ArticleIdList": ["10.1196/annals.1352.010", "16387689"]}, {"Citation": "Begum A. N., Jones M. R., Lim G. P., et al. Curcumin structure-function, bioavailability, and efficacy in models of neuro inflammation and Alzheimer\u2019s disease. Journal of Pharmacology and Experimental Therapeutics. 2008;326(1):196\u2013208. doi: 10.1124/jpet.108.137455.", "ArticleIdList": ["10.1124/jpet.108.137455", "PMC2527621", "18417733"]}, {"Citation": "Malik J., Karan M., Vasisht K. Nootropic, anxiolytic and CNS-depressant studies on different plant sources of shankhpushpi. Pharmaceutical Biology. 2011;49(12):1234\u20131242. doi: 10.3109/13880209.2011.584539.", "ArticleIdList": ["10.3109/13880209.2011.584539", "21846173"]}, {"Citation": "Singh R. H., Narsimhamurthy K., Singh G. Neuronutrient impact of ayurvedic rasayana therapy in brain aging. Biogerontology. 2008;9(6):369\u2013374. doi: 10.1007/s10522-008-9185-z.", "ArticleIdList": ["10.1007/s10522-008-9185-z", "18931935"]}, {"Citation": "Mukherjee P. K., Kumar V., Kumar N. S., Heinrich M. The ayurvedic medicine Clitoria ternatea-from traditional use to scientific assessment. Journal of Ethnopharmacology. 2008;120(3):291\u2013301. doi: 10.1016/j.jep.2008.09.009.", "ArticleIdList": ["10.1016/j.jep.2008.09.009", "18926895"]}, {"Citation": "Nahata A., Patil U. K., Dixit V. K. Effect of Convulvulus pluricaulis Choisy. on learning behaviour and memory enhancement activity in rodents. Natural Product Research. 2008;22(16):1472\u20131482. doi: 10.1080/14786410802214199.", "ArticleIdList": ["10.1080/14786410802214199", "19023811"]}, {"Citation": "Singh B., Rastogi R. P. A reinvestigation of the triterpenes of Centella asiatica. Phytochemistry. 1969;8(5):917\u2013921. doi: 10.1016/s0031-9422(00)85884-7.", "ArticleIdList": ["10.1016/s0031-9422(00)85884-7"]}, {"Citation": "Dhanasekaran M., Holcomb L. A., Hitt A. R., et al. Centella asiatica extract selectively decreases amyloid \u03b2 levels in hippocampus of Alzheimer\u2019s disease animal model. Phytotherapy Research. 2009;23(1):14\u201319. doi: 10.1002/ptr.2405.", "ArticleIdList": ["10.1002/ptr.2405", "19048607"]}, {"Citation": "Perluigi M., Joshi G., Sultana R., et al. In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. Journal of Neuroscience Research. 2006;84(2):418\u2013426. doi: 10.1002/jnr.20879.", "ArticleIdList": ["10.1002/jnr.20879", "16634068"]}, {"Citation": "Scapagnini G., Butterfield D. A., Colombrita C., Sultana R., Pascale A., Calabrese V. Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxidants & Redox Signaling. 2004;6(5):811\u2013818. doi: 10.1089/ars.2004.6.811.", "ArticleIdList": ["10.1089/ars.2004.6.811", "15345140"]}, {"Citation": "Sultana R., Ravagna A., Mohmmad-Abdul H., Calabrese V., Butterfield D. A. Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. Journal of Neurochemistry. 2005;92(4):749\u2013758. doi: 10.1111/j.1471-4159.2004.02899.x.", "ArticleIdList": ["10.1111/j.1471-4159.2004.02899.x", "15686476"]}, {"Citation": "Bhanumathy M., Harish M. S., Shivaprasad H. N., Sushma G. Nootropic activity of Celastrus paniculatus seed. Pharmaceutical Biology. 2010;48(3):324\u2013327. doi: 10.3109/13880200903127391.", "ArticleIdList": ["10.3109/13880200903127391", "20645820"]}, {"Citation": "Divino da Rocha M., Pereira Dias Viegas F., Cristina Campos H., et al. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimers disease. CNS & Neurological Disorders-Drug Targets. 2011;10(2):251\u2013270. doi: 10.2174/187152711794480429.", "ArticleIdList": ["10.2174/187152711794480429", "20874701"]}, {"Citation": "Lyle N., Gomes A., Sur T., et al. The role of antioxidant properties of Nardostachys jatamansi in alleviation of the symptoms of the chronic fatigue syndrome. Behavioural Brain Research. 2009;202(2):285\u2013290. doi: 10.1016/j.bbr.2009.04.005.", "ArticleIdList": ["10.1016/j.bbr.2009.04.005", "19375459"]}, {"Citation": "Smith J. V., Luo Y. Studies on molecular mechanisms of Ginkgo biloba extract. Applied Microbiology and Biotechnology. 2004;64(4):465\u2013472. doi: 10.1007/s00253-003-1527-9.", "ArticleIdList": ["10.1007/s00253-003-1527-9", "14740187"]}, {"Citation": "Maurer K., Ihl R., Dierks T., Fr\u00f6lich L. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. Journal of Psychiatric Research. 1997;31(6):645\u2013655. doi: 10.1016/s0022-3956(97)00022-8.", "ArticleIdList": ["10.1016/s0022-3956(97)00022-8", "9447569"]}, {"Citation": "Luo Y. Ginkgo biloba neuroprotection: therapeutic implications in Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease. 2001;3(4):401\u2013407. doi: 10.3233/jad-2001-3407.", "ArticleIdList": ["10.3233/jad-2001-3407", "12214044"]}, {"Citation": "Shinji S., Yasukazu T., Hatsue W., Kazuo K., Machiko I., Naoki M. Analysis of brain cell activation by nanosized particles of Ginkgo biloba extract. International Journal of Plant Physiology and Biochemistry. 2011;3(3):28\u201333."}, {"Citation": "Chan P.-C., Xia Q., Fu P. P. Ginkgo biloba leave extract: biological, medicinal, and toxicological effects. Journal of Environmental Science and Health, Part C. 2007;25(3):211\u2013244. doi: 10.1080/10590500701569414.", "ArticleIdList": ["10.1080/10590500701569414", "17763047"]}, {"Citation": "Paris D., Mathura V., Ait-Ghezala G., et al. Flavonoids lower Alzheimers A\u03b2 production via an NFkB dependent mechanism. Bioinformation. 2011;6(6):229\u2013236. doi: 10.6026/97320630006229.", "ArticleIdList": ["10.6026/97320630006229", "PMC3124791", "21738321"]}, {"Citation": "Lu J.-H., Ardah M. T., Durairajan S. S. K., et al. Baicalein inhibits formation of \u03b1-synuclein oligomers within living cells and prevents A\u03b2 peptide fibrillation and oligomerisation. Chembiochem. 2011;12(4):615\u2013624. doi: 10.1002/cbic.201000604.", "ArticleIdList": ["10.1002/cbic.201000604", "21271629"]}, {"Citation": "Gu X.-H., Xu L.-J., Liu Z.-Q., et al. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer\u2019s disease. Behavioural Brain Research. 2016;311:309\u2013321. doi: 10.1016/j.bbr.2016.05.052.", "ArticleIdList": ["10.1016/j.bbr.2016.05.052", "27233830"]}, {"Citation": "Priprem A., Watanatorn J., Sutthiparinyanont S., Phachonpai W., Muchimapura S. Anxiety and cognitive effects of quercetin liposomes in rats. Nanomedicine: Nanotechnology, Biology and Medicine. 2008;4(1):70\u201378. doi: 10.1016/j.nano.2007.12.001.", "ArticleIdList": ["10.1016/j.nano.2007.12.001", "18249157"]}, {"Citation": "Lu J., Wu D.-m., Zheng Y.-l., et al. Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity. The Journal of Pathology. 2010;222(2):199\u2013212. doi: 10.1002/path.2754.", "ArticleIdList": ["10.1002/path.2754", "20690163"]}, {"Citation": "Shimmyo Y., Kihara T., Akaike A., Niidome T., Sugimoto H. Multifunction of myricetin on A beta: neuroprotection via a conformational change of A beta and reduction of A beta via the interference of secretases. Journal of Neuroscience Research. 2007;86(2):368\u2013377.", "ArticleIdList": ["17722071"]}, {"Citation": "Ramezani M., Darbandi N., Khodagholi F., Hashemi A. Myricetin protects hippocampal CA3 pyramidal neurons and improves learning and memory impairments in rats with Alzheimer\u02bcs disease. Neural Regeneration Research. 2016;11(12):p. 1976.", "ArticleIdList": ["PMC5270437", "28197195"]}, {"Citation": "Vall\u00e9s S. L., Borr\u00e1s C., Gambini J., et al. Oestradiol or genistein rescues neurons from amyloid beta-induced cell death by inhibiting activation of p38. Aging Cell. 2008;7(1):112\u2013118. doi: 10.1111/j.1474-9726.2007.00356.x.", "ArticleIdList": ["10.1111/j.1474-9726.2007.00356.x", "18031570"]}, {"Citation": "Valles S. L., Dolz-Gaiton P., Gambini J., et al. Estradiol or genistein prevent Alzheimer\u2019s disease-associated inflammation correlating with an increase PPAR\u03b3 expression in cultured astrocytes. Brain Research. 2010;1312:138\u2013144. doi: 10.1016/j.brainres.2009.11.044.", "ArticleIdList": ["10.1016/j.brainres.2009.11.044", "19948157"]}, {"Citation": "Ma W., Ding B., Yu H., Yuan L., Xi Y., Xiao R. Genistein alleviates \u03b2-amyloid-induced inflammatory damage through regulating toll-like receptor 4/nuclear factor \u03baB. Journal of Medicinal Food. 2015;18(3):273\u2013279. doi: 10.1089/jmf.2014.3150.", "ArticleIdList": ["10.1089/jmf.2014.3150", "PMC4350449", "25384233"]}, {"Citation": "Tsai T. H. Concurrent measurement of unbound genistein in the blood, brain and bile of anesthetized rats using microdialysis and its pharmacokinetic application. Journal of Chromatography. A. 2005;1073(1-2):317\u2013322. doi: 10.1016/j.chroma.2004.10.048.", "ArticleIdList": ["10.1016/j.chroma.2004.10.048", "15909536"]}, {"Citation": "Chen W., Chen G. Danshen (Salvia miltiorrhiza Bunge): a prospective healing sage for cardiovascular diseases. Current Pharmaceutical Design. 2017;23(34):5125\u20135135. doi: 10.2174/1381612823666170822101112.", "ArticleIdList": ["10.2174/1381612823666170822101112", "28828985"]}, {"Citation": "Jiang R.-W., Lau K.-M., Hon P.-M., Mak T., Woo K.-S., Fung K.-P. Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Current Medicinal Chemistry. 2005;12(2):237\u2013246. doi: 10.2174/0929867053363397.", "ArticleIdList": ["10.2174/0929867053363397", "15638738"]}, {"Citation": "Tang Y., Huang D., Zhang M.-H., et al. Salvianolic acid B inhibits A\u03b2 generation by modulating BACE1 activity in SH-SY5Y-APPsw cells. Nutrients. 2016;8(6):p. 333. doi: 10.3390/nu8060333.", "ArticleIdList": ["10.3390/nu8060333", "PMC4924174", "27258307"]}, {"Citation": "Mori T., Koyama N., Guillot-Sestier M.-V., Tan J., Town T. Ferulic acid is a nutraceutical \u03b2-secretase modulator that improves behavioral impairment and Alzheimer-like pathology in transgenic mice. PloS One. 2013;8(2) doi: 10.1371/journal.pone.0055774.e55774", "ArticleIdList": ["10.1371/journal.pone.0055774", "PMC3568151", "23409038"]}, {"Citation": "Srinivasan M., Sudheer A. R., Menon V. P. Ferulic acid: therapeutic potential through its antioxidant property. Journal of Clinical Biochemistry and Nutrition. 2007;40(2):92\u2013100. doi: 10.3164/jcbn.40.92.", "ArticleIdList": ["10.3164/jcbn.40.92", "PMC2127228", "18188410"]}, {"Citation": "Asai M., Iwata N., Yoshikawa A., et al. Berberine alters the processing of Alzheimer\u2019s amyloid precursor protein to decrease A\u03b2 secretion. Biochemical and Biophysical Research Communications. 2007;352(2):498\u2013502. doi: 10.1016/j.bbrc.2006.11.043.", "ArticleIdList": ["10.1016/j.bbrc.2006.11.043", "17125739"]}, {"Citation": "Jung H. A., Min B.-S., Yokozawa T., Lee J.-H., Kim Y. S., Choi J. S. Anti-alzheimer and antioxidant activities of coptidis rhizoma alkaloids. Biological and Pharmaceutical Bulletin. 2009;32(8):1433\u20131438. doi: 10.1248/bpb.32.1433.", "ArticleIdList": ["10.1248/bpb.32.1433", "19652386"]}, {"Citation": "Zhu Z., Li C., Wang X., et al. 2,2\u2032,4\u2032-Trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice. Journal of Neurochemistry. 2010;114(2):374\u2013385. doi: 10.1111/j.1471-4159.2010.06751.x.", "ArticleIdList": ["10.1111/j.1471-4159.2010.06751.x", "20412384"]}, {"Citation": "Youn K., Jun M. Biological evaluation and docking analysis of potent BACE1 inhibitors from Boesenbergia rotunda. Nutrients. 2019;11(3):p. 662. doi: 10.3390/nu11030662.", "ArticleIdList": ["10.3390/nu11030662", "PMC6471523", "30893825"]}, {"Citation": "James S., Aparna J. S., Paul A. M., et al. Cardamonin inhibits colonic neoplasia through modulation of microRNA expression. Scientific Reports. 2017;7(1):13945\u201314016. doi: 10.1038/s41598-017-14253-8.", "ArticleIdList": ["10.1038/s41598-017-14253-8", "PMC5655681", "29066742"]}, {"Citation": "Cao G., Su P., Zhang S., et al. Ginsenoside Re reduces A\u03b2 production by activating PPAR\u03b3 to inhibit BACE1 in N2a/APP695 cells. European Journal of Pharmacology. 2016;793:101\u2013108. doi: 10.1016/j.ejphar.2016.11.006.", "ArticleIdList": ["10.1016/j.ejphar.2016.11.006", "27840193"]}, {"Citation": "Qi C., Bao J., Wang J., et al. Asperterpenes A and B, two unprecedented meroterpenoids from Aspergillus terreus with BACE1 inhibitory activities. Chemical Science. 2016;7(10):6563\u20136572. doi: 10.1039/c6sc02464e.", "ArticleIdList": ["10.1039/c6sc02464e", "PMC5131395", "28042460"]}, {"Citation": "Descamps O., Spilman P., Zhang Q., et al. A\u03b2PP-selective BACE inhibitors (ASBI): novel class of therapeutic agents for Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease. 2013;37(2):343\u2013355. doi: 10.3233/jad-130578.", "ArticleIdList": ["10.3233/jad-130578", "PMC3971881", "23948888"]}, {"Citation": "Serrano F. G., Tapia-Rojas C., Carvajal F. J., Hancke J., Cerpa W, Inestrosa N. C. Andrographolide reduces cognitive impairment in young and mature A\u03b2PPswe/PS-1 mice. Molecular Neurodegeneration. 2014;9(1):61\u201318. doi: 10.1186/1750-1326-9-61.", "ArticleIdList": ["10.1186/1750-1326-9-61", "PMC4414355", "25524173"]}, {"Citation": "Rivera D. S., Lindsay C., Codocedo J. F., et al. Andrographolide recovers cognitive impairment in a natural model of Alzheimer\u2019s disease (Octodon degus) Neurobiology of Aging. 2016;46:204\u2013220. doi: 10.1016/j.neurobiolaging.2016.06.021.", "ArticleIdList": ["10.1016/j.neurobiolaging.2016.06.021", "27505720"]}, {"Citation": "Lindsay C. B., Zolezzi J. M., Rivera D. S., Cisternas P., Bozinovic F., Inestrosa N. C. Andrographolide reduces neuroinflammation and oxidative stress in aged Octodon degus. Molecular Neurobiology. 2020;57(2):1131\u20131145. doi: 10.1007/s12035-019-01784-6.", "ArticleIdList": ["10.1007/s12035-019-01784-6", "31701436"]}, {"Citation": "Mulik R. S., M\u00f6nkk\u00f6nen J., Juvonen R. O., Mahadik K. R., Paradkar A. R. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model. Molecular Pharmaceutics. 2010;7(3):815\u2013825. doi: 10.1021/mp900306x.", "ArticleIdList": ["10.1021/mp900306x", "20230014"]}, {"Citation": "Tiwari S. K., Agarwal S., Seth B., et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer\u2019s disease ModelviaCanonical Wnt/\u03b2-catenin pathway. ACS Nano. 2014;8(1):76\u2013103. doi: 10.1021/nn405077y.", "ArticleIdList": ["10.1021/nn405077y", "24467380"]}, {"Citation": "Mathew A., Fukuda T., Nagaoka Y., et al. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease. PLoS One. 2012;7(3) doi: 10.1371/journal.pone.0032616.e32616", "ArticleIdList": ["10.1371/journal.pone.0032616", "PMC3293842", "22403681"]}, {"Citation": "Cheng K. K., Yeung C. F., Ho S. W., Chow S. F., Chow A. H. L., Baum L. Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer\u2019s disease Tg2576 mice. The AAPS Journal. 2013;15(2):324\u2013336. doi: 10.1208/s12248-012-9444-4.", "ArticleIdList": ["10.1208/s12248-012-9444-4", "PMC3675736", "23229335"]}, {"Citation": "Sadegh Malvajerd S., Azadi A., Izadi Z., et al. Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers: preparation, optimization, and pharmacokinetic evaluation. ACS Chemical Neuroscience. 2018;10(1):728\u2013739. doi: 10.1021/acschemneuro.8b00510.", "ArticleIdList": ["10.1021/acschemneuro.8b00510", "30335941"]}, {"Citation": "Mourtas S., Lazar A. N., Markoutsa E., Duyckaerts C., Antimisiaris S. G. Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. European Journal of Medicinal Chemistry. 2014;80:175\u2013183. doi: 10.1016/j.ejmech.2014.04.050.", "ArticleIdList": ["10.1016/j.ejmech.2014.04.050", "24780594"]}, {"Citation": "Zhao G., Dong X., Sun Y. Self-assembled curcumin-poly(carboxybetaine methacrylate) conjugates: potent nano-inhibitors against amyloid \u03b2-protein Fibrillogenesis and cytotoxicity. Langmuir. 2018;35(5):1846\u20131857. doi: 10.1021/acs.langmuir.8b01921.", "ArticleIdList": ["10.1021/acs.langmuir.8b01921", "30134656"]}, {"Citation": "Huo X., Zhang Y., Jin X., Li Y., Zhang L. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid \u03b2 aggregation in Alzheimer\u2019s disease. Journal of Photochemistry and Photobiology B: Biology. 2019;190:98\u2013102. doi: 10.1016/j.jphotobiol.2018.11.008.", "ArticleIdList": ["10.1016/j.jphotobiol.2018.11.008", "30504054"]}, {"Citation": "Kakkar V., Kaur I. P. Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food and Chemical Toxicology. 2011;49(11):2906\u20132913. doi: 10.1016/j.fct.2011.08.006.", "ArticleIdList": ["10.1016/j.fct.2011.08.006", "21889563"]}, {"Citation": "Hoppe J. B., Coradini K., Frozza R. L., et al. Free and nanoencapsulated curcumin suppress \u03b2-amyloid-induced cognitive impairments in rats: Involvement of BDNF and Akt/GSK-3\u03b2 signaling pathway. Neurobiology of Learning and Memory. 2013;106:134\u2013144. doi: 10.1016/j.nlm.2013.08.001.", "ArticleIdList": ["10.1016/j.nlm.2013.08.001", "23954730"]}, {"Citation": "Meng F., Asghar S., Gao S., et al. A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer\u2019s disease. Colloids and Surfaces B: Biointerfaces. 2015;134:88\u201397. doi: 10.1016/j.colsurfb.2015.06.025.", "ArticleIdList": ["10.1016/j.colsurfb.2015.06.025", "26162977"]}, {"Citation": "Singh N. A., Bhardwaj V., Ravi C., Ramesh N., Mandal A. K. A., Khan Z. A. EGCG nanoparticles attenuate aluminum chloride induced neurobehavioral deficits, beta amyloid and tau pathology in a rat model of Alzheimer\u2019s disease. Frontiers in Aging Neuroscience. 2018;10:p. 244. doi: 10.3389/fnagi.2018.00244.", "ArticleIdList": ["10.3389/fnagi.2018.00244", "PMC6099078", "30150930"]}, {"Citation": "Cano A., Ettcheto M., Chang J.-H., et al. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer\u2019s disease mice model. Journal of Controlled Release. 2019;301:62\u201375. doi: 10.1016/j.jconrel.2019.03.010.", "ArticleIdList": ["10.1016/j.jconrel.2019.03.010", "PMC6510952", "30876953"]}, {"Citation": "Hoyos-Ceballos G. P., S\u00e1nchez-Giraldo V., Mendivil-Perez M., et al. Design of epigallocatechin gallate loaded PLGA/PF127 nanoparticles and their effect upon an oxidative stress model. Journal of Drug Delivery Science and Technology. 2018;48:152\u2013160. doi: 10.1016/j.jddst.2018.09.010.", "ArticleIdList": ["10.1016/j.jddst.2018.09.010"]}, {"Citation": "Smith A., Giunta B., Bickford P. C., Fountain M., Tan J., Shytle R. D. Nanolipidic particles improve the bioavailability and \u03b1-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer\u2019s disease. International Journal of Pharmaceutics. 2010;389(1-2):207\u2013212. doi: 10.1016/j.ijpharm.2010.01.012.", "ArticleIdList": ["10.1016/j.ijpharm.2010.01.012", "PMC5831366", "20083179"]}, {"Citation": "Zhang J., Zhou X., Yu Q., et al. Epigallocatechin-3-gallate (EGCG)-Stabilized selenium nanoparticles coated with tet-1 peptide to reduce amyloid-\u03b2 aggregation and cytotoxicity. ACS Applied Materials & Interfaces. 2014;6(11):8475\u20138487. doi: 10.1021/am501341u.", "ArticleIdList": ["10.1021/am501341u", "24758520"]}, {"Citation": "Lohan S., Raza K., Mehta S. K., Bhatti G. K., Saini S., Singh B. Anti-Alzheimer\u2019s potential of berberine using surface decorated multi-walled carbon nanotubes: a preclinical evidence. International Journal of Pharmaceutics. 2017;530(1-2):263\u2013278. doi: 10.1016/j.ijpharm.2017.07.080.", "ArticleIdList": ["10.1016/j.ijpharm.2017.07.080", "28774853"]}, {"Citation": "Soudi S. A., Nounou M. I., Sheweita S. A., Ghareeb D. A., Younis L. K., El-Khordagui L. K. Protective effect of surface-modified berberine nanoparticles against LPS-induced neurodegenerative changes: a preclinical study. Drug Delivery and Translational Research. 2019;9(5):906\u2013919. doi: 10.1007/s13346-019-00626-1.", "ArticleIdList": ["10.1007/s13346-019-00626-1", "30868509"]}, {"Citation": "Kumar P., Sharma G., Kumar R., et al. Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and bio distribution evidences. International Journal of Pharmaceutics. 2016;515(1-2):307\u2013314. doi: 10.1016/j.ijpharm.2016.10.024.", "ArticleIdList": ["10.1016/j.ijpharm.2016.10.024", "27756627"]}, {"Citation": "Dhawan S., Kapil R., Singh B. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. Journal of Pharmacy and Pharmacology. 2011;63(3):342\u2013351. doi: 10.1111/j.2042-7158.2010.01225.x.", "ArticleIdList": ["10.1111/j.2042-7158.2010.01225.x", "21749381"]}, {"Citation": "Kuo Y.-C., Chen I.-Y., Rajesh R. Use of functionalized liposomes loaded with antioxidants to permeate the blood-brain barrier and inhibit \u03b2-amyloid-induced neurodegeneration in the brain. Journal of the Taiwan Institute of Chemical Engineers. 2018;87:1\u201314. doi: 10.1016/j.jtice.2018.03.001.", "ArticleIdList": ["10.1016/j.jtice.2018.03.001"]}, {"Citation": "Phachonpai W., Wattanathorn J., Muchimapura S., Tong-Un T., Preechagoon D. Neuroprotective effect of quercetin encapsulated liposomes: a novel therapeutic strategy against Alzheimer\u2019s disease. American Journal of Applied Sciences. 2010;7(4):480\u2013485. doi: 10.3844/ajassp.2010.480.485.", "ArticleIdList": ["10.3844/ajassp.2010.480.485"]}, {"Citation": "Aluani D., Tzankova V., Yordanov Y., Kondeva-Burdina M., Yoncheva K. In vitro protective effects of encapsulated quercetin in neuronal models of oxidative stress injury. Biotechnology & Biotechnological Equipment. 2017;31(5):1055\u20131063. doi: 10.1080/13102818.2017.1347523.", "ArticleIdList": ["10.1080/13102818.2017.1347523"]}, {"Citation": "Frozza R. L., Bernardi A., Hoppe J. B., et al. Lipid-core nanocapsules improve the effects of resveratrol against A\u03b2-induced neuroinflammation. Journal of Biomedical Nanotechnology. 2013;9(12):2086\u20132104. doi: 10.1166/jbn.2013.1709.", "ArticleIdList": ["10.1166/jbn.2013.1709", "24266263"]}, {"Citation": "Frozza R. L., Bernardi A., Hoppe J. B., et al. Neuroprotective effects of resveratrol against A\u03b2 administration in rats are improved by lipid-core nanocapsules. Molecular Neurobiology. 2013;47(3):1066\u20131080. doi: 10.1007/s12035-013-8401-2.", "ArticleIdList": ["10.1007/s12035-013-8401-2", "23315270"]}, {"Citation": "Sun J., Wei C., Liu Y., et al. Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer\u2019s disease. Biomaterials. 2019;197:417\u2013431. doi: 10.1016/j.biomaterials.2018.12.027.", "ArticleIdList": ["10.1016/j.biomaterials.2018.12.027", "30638753"]}, {"Citation": "Lu X., Ji C., Xu H., et al. Resveratrol-loaded polymeric micelles protect cells from A\u03b2-induced oxidative stress. International Journal of Pharmaceutics. 2009;375(1-2):89\u201396. doi: 10.1016/j.ijpharm.2009.03.021.", "ArticleIdList": ["10.1016/j.ijpharm.2009.03.021", "19481694"]}, {"Citation": "Elnaggar Y., Etman S., Abdelmonsif D., Abdallah O. Novel piperine-loaded tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer\u2019s disease: pharmaceutical, biological, and\u2009toxicological studies. International Journal of Nanomedicine. 2015;10:p. 5459. doi: 10.2147/ijn.s87336.", "ArticleIdList": ["10.2147/ijn.s87336", "PMC4556290", "26346130"]}, {"Citation": "Etman S. M., Elnaggar Y. S. R., Abdelmonsif D. A., Abdallah O. Y. Oral brain-targeted microemulsion for enhanced piperine delivery in Alzheimer\u2019s disease therapy: in vitro appraisal, in vivo activity, and nanotoxicity. AAPS Pharmscitech. 2018;19(8):3698\u20133711. doi: 10.1208/s12249-018-1180-3.", "ArticleIdList": ["10.1208/s12249-018-1180-3", "30238305"]}, {"Citation": "Yusuf M., Khan M., Khan R. A., Ahmed B. Preparation, characterization, in vivo and biochemical evaluation of brain targeted piperine solid lipid nanoparticles in an experimentally induced Alzheimer\u2019s disease model. Journal of Drug Targeting. 2013;21(3):300\u2013311. doi: 10.3109/1061186x.2012.747529.", "ArticleIdList": ["10.3109/1061186x.2012.747529", "23231324"]}, {"Citation": "Kulkarni P. V., Roney C. A., Antich P. P., Bonte F. J., Raghu A. V., Aminabhavi T. M. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer\u2019s disease. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2010;2(1):35\u201347. doi: 10.1002/wnan.59.", "ArticleIdList": ["10.1002/wnan.59", "20049829"]}, {"Citation": "Jaruszewski K. M., Ramakrishnan S., Poduslo J. F., Kandimalla K. K. Chitosan enhances the stability and targeting of immuno-nanovehicles to cerebro-vascular deposits of Alzheimer\u2019s disease amyloid protein. Nanomedicine: Nanotechnology, Biology and Medicine. 2012;8(2):250\u2013260. doi: 10.1016/j.nano.2011.06.008.", "ArticleIdList": ["10.1016/j.nano.2011.06.008", "PMC3767177", "21704598"]}, {"Citation": "Bernardi A., Frozza R. L., Meneghetti A., et al. Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by A\u03b21\u201342 in Alzheimer\u2019s disease models. International Journal of Nanomedicine. 2012;7:p. 4927. doi: 10.2147/ijn.s35333.", "ArticleIdList": ["10.2147/ijn.s35333", "PMC3446842", "23028221"]}, {"Citation": "Prakash J., Chouhan S., Yadav S. K., Westfall S., Rai S. N., Singh S. P. Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons. Neurochemical Research. 2014;39(12):2527\u20132536. doi: 10.1007/s11064-014-1443-7.", "ArticleIdList": ["10.1007/s11064-014-1443-7", "25403619"]}, {"Citation": "Rai S. N., Birla H., Singh S. S., et al. Mucuna pruriens protects against MPTP intoxicated neuroinflammation in Parkinson\u2019s disease through NF-\u03baB/pAKT signaling pathways. Frontiers in Aging Neuroscience. 2017;9:p. 421. doi: 10.3389/fnagi.2017.00421.", "ArticleIdList": ["10.3389/fnagi.2017.00421", "PMC5742110", "29311905"]}, {"Citation": "Rai S. N., Birla H., Zahra W., Singh S. S., Singh S. P. Immunomodulation of Parkinson\u2019s disease using Mucuna pruriens (Mp) Journal of Chemical Neuroanatomy. 2017;85:27\u201335. doi: 10.1016/j.jchemneu.2017.06.005.", "ArticleIdList": ["10.1016/j.jchemneu.2017.06.005", "28642128"]}, {"Citation": "Yadav S. K., Rai S. N., Singh S. P. Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model. Journal of Chemical Neuroanatomy. 2017;80:1\u201310. doi: 10.1016/j.jchemneu.2016.11.009.", "ArticleIdList": ["10.1016/j.jchemneu.2016.11.009", "27919828"]}, {"Citation": "Singh B., Pandey S., Rumman M., et al. Neuroprotective and neurorescue mode of action of Bacopa monnieri (L.) Wettst in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson\u2019s disease: an in silico and in vivo study. Frontiers in Pharmacology. 2021;12 doi: 10.3389/fphar.2021.616413.616413", "ArticleIdList": ["10.3389/fphar.2021.616413", "PMC8007855", "33796021"]}, {"Citation": "Abbaoui A., Chatoui H., El Hiba O., Gamrani H. Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: a possible link with Parkinson\u2019s disease. Neuroscience Letters. 2017;660:103\u2013108. doi: 10.1016/j.neulet.2017.09.032.", "ArticleIdList": ["10.1016/j.neulet.2017.09.032", "28919537"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "8"}, {"Year": "2021", "Month": "5", "Day": "28"}, {"Year": "2021", "Month": "7", "Day": "2", "Hour": "6", "Minute": "38"}, {"Year": "2021", "Month": "7", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "6", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["34211570", "PMC8208882", "10.1155/2021/5578574"]}}], "PubmedBookArticle": []}